抗 SARS-CoV-2 血清阳性在新诊断为 1 型糖尿病的儿童中的表现：一项病例对照研究。
Anti-SARS-CoV-2 Seropositivity Among Children With Newly Diagnosed Type 1 Diabetes Mellitus: A Case-Control Study.
机构信息
Department of Pediatrics, Semmelweis University, Hungary.
Department of Pediatrics, Semmelweis University, Hungary
出版信息
Indian Pediatr. 2022 Oct 15;59(10):809-810. doi: 10.1007/s13312-022-2626-y. Epub 2022 Aug 26.
Abstract
A sudden increase in the number of children with newly diagnosed type 1 diabetes mellitus (T1DM) was experienced during the third wave of COVID-19 epidemic in Hungary. The newly diagnosed T1DM patients had a significantly higher rate of anti-SARS-CoV-2 positivity as compared to prevalent T1DM children [OR (95% CI) 3.74 (1,08,13.55); P=0.04]. The relationship between SARS-CoV-2 infection and diabetes needs to be investigated further.
摘要
在匈牙利 COVID-19 疫情的第三波中，新诊断出的 1 型糖尿病（T1DM）患儿数量突然增加。与普通 T1DM 患儿相比，新诊断的 T1DM 患者的抗 SARS-CoV-2 阳性率显著更高[比值比（95%CI）3.74（1,08,13.55）；P=0.04]。SARS-CoV-2 感染与糖尿病之间的关系需要进一步研究。
相似文献
1
Anti-SARS-CoV-2 Seropositivity Among Children With Newly Diagnosed Type 1 Diabetes Mellitus: A Case-Control Study.抗 SARS-CoV-2 血清阳性在新诊断为 1 型糖尿病的儿童中的表现：一项病例对照研究。
Indian Pediatr. 2022 Oct 15;59(10):809-810. doi: 10.1007/s13312-022-2626-y. Epub 2022 Aug 26.
2
Role of the SARS-CoV-2 virus in the appearance of new onset type 1 diabetes mellitus in children in Gran Canaria, Spain.西班牙加那利群岛上 SARS-CoV-2 病毒在儿童新发 1 型糖尿病发病中的作用。
J Pediatr Endocrinol Metab. 2022 Jan 17;35(3):393-397. doi: 10.1515/jpem-2021-0727. Print 2022 Mar 28.
3
Changes in the presentation of newly diagnosed type 1 diabetes in children during the COVID-19 pandemic in a tertiary center in Southern Turkey.土耳其南部一家三级中心在 COVID-19 大流行期间新诊断的 1 型糖尿病患儿临床表现的变化。
J Pediatr Endocrinol Metab. 2021 Jul 22;34(10):1303-1309. doi: 10.1515/jpem-2021-0287. Print 2021 Oct 26.
4
Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.1 型糖尿病儿童和成人中 SARS-CoV-2 抗体的流行率。
Diabetes Technol Ther. 2021 Jul;23(7):517-521. doi: 10.1089/dia.2020.0609. Epub 2021 Feb 25.
5
Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case-control study using .糖尿病状况和其他因素与 SARS-CoV-2 感染期间血栓形成和血栓栓塞事件风险的相关性：使用. 的全国回顾性病例对照研究
BMJ Open. 2023 Jul 9;13(7):e071475. doi: 10.1136/bmjopen-2022-071475.
6
Children, adolescents, and young adults hospitalized with COVID-19 and diabetes in summer 2021.2021 年夏季因 COVID-19 和糖尿病住院的儿童、青少年和青年。
Pediatr Diabetes. 2022 Nov;23(7):961-967. doi: 10.1111/pedi.13396. Epub 2022 Aug 5.
7
Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.比利时大流行期间新发 1 型糖尿病患儿中的抗 SARS-CoV-2 抗体。
J Pediatr Endocrinol Metab. 2021 Jul 20;34(10):1319-1322. doi: 10.1515/jpem-2021-0289. Print 2021 Oct 26.
8
Children with Newly Diagnosed Type 1 Diabetes Before and During the COVID-19 Pandemic.新冠疫情之前及期间新诊断的1型糖尿病患儿。
J Clin Res Pediatr Endocrinol. 2022 Aug 25;14(3):366-367. doi: 10.4274/jcrpe.galenos.2022.2022-3-22. Epub 2022 May 31.
9
SARS-CoV-2 Seroprevalence in Individuals With Type 1 and Type 2 Diabetes Compared With Controls.SARS-CoV-2 血清流行率在 1 型和 2 型糖尿病个体与对照者中的比较。
Endocr Pract. 2022 Feb;28(2):191-198. doi: 10.1016/j.eprac.2021.12.009. Epub 2021 Dec 14.
10
No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.未发现 COVID-19 对 1 型糖尿病自身免疫发展的影响，也未发现新诊断的 1 型糖尿病患者相对于健康受试者 SARS-CoV-2 抗体的频率增加。
Acta Diabetol. 2023 Oct;60(10):1301-1307. doi: 10.1007/s00592-023-02103-1. Epub 2023 May 12.
引用本文的文献
1
Post-COVID Metabolic Fallout: A Growing Threat of New-Onset and Exacerbated Diabetes.新冠后代谢后遗症：新发和加重型糖尿病的威胁日益增加。
Biomedicines. 2025 Jun 16;13(6):1482. doi: 10.3390/biomedicines13061482.
2
Type 1 Diabetes and COVID-19: A Literature Review and Possible Management.1型糖尿病与2019冠状病毒病：文献综述及可能的管理方法
Int J Endocrinol Metab. 2023 Oct 23;21(4):e139768. doi: 10.5812/ijem-139768. eCollection 2023 Oct.
3
Endocrinological Involvement in Children and Adolescents Affected by COVID-19: A Narrative Review.新型冠状病毒肺炎（COVID-19）对儿童和青少年内分泌系统的影响：一篇叙述性综述
J Clin Med. 2023 Aug 11;12(16):5248. doi: 10.3390/jcm12165248.
4
Diabetes Mellitus after SARS-CoV-2 Infection: An Epidemiological Review.新型冠状病毒感染后糖尿病：一项流行病学综述。
Life (Basel). 2023 May 23;13(6):1233. doi: 10.3390/life13061233.
本文引用的文献
1
Incidence of Type 1 Diabetes in Children and Adolescents During the COVID-19 Pandemic in Germany: Results From the DPV Registry.德国 COVID-19 大流行期间儿童和青少年 1 型糖尿病的发病率：来自 DPV 登记处的结果。
Diabetes Care. 2022 Aug 1;45(8):1762-1771. doi: 10.2337/dc21-0969.
2
Risk for Newly Diagnosed Diabetes >30 Days After SARS-CoV-2 Infection Among Persons Aged <18 Years - United States, March 1, 2020-June 28, 2021.2020 年 3 月 1 日至 2021 年 6 月 28 日期间，年龄<18 岁的 SARS-CoV-2 感染者在新冠病毒感染后 30 天以上新发糖尿病的风险。
MMWR Morb Mortal Wkly Rep. 2022 Jan 14;71(2):59-65. doi: 10.15585/mmwr.mm7102e2.
3
Anti-SARS-CoV-2 antibodies in new-onset type 1 diabetes in children during pandemic in Belgium.比利时大流行期间新发 1 型糖尿病患儿中的抗 SARS-CoV-2 抗体。
J Pediatr Endocrinol Metab. 2021 Jul 20;34(10):1319-1322. doi: 10.1515/jpem-2021-0289. Print 2021 Oct 26.
4
Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 Diabetes.1 型糖尿病儿童和成人中 SARS-CoV-2 抗体的流行率。
Diabetes Technol Ther. 2021 Jul;23(7):517-521. doi: 10.1089/dia.2020.0609. Epub 2021 Feb 25.
5
SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas.SARS-CoV-2 感染并在人体内分泌和外分泌胰腺细胞中复制。
Nat Metab. 2021 Feb;3(2):149-165. doi: 10.1038/s42255-021-00347-1. Epub 2021 Feb 3.
6
New-Onset Diabetes in Covid-19.新冠病毒感染引发的新发糖尿病
N Engl J Med. 2020 Aug 20;383(8):789-790. doi: 10.1056/NEJMc2018688. Epub 2020 Jun 12.
7
Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis.SARS冠状病毒功能性受体ACE2蛋白的组织分布。理解SARS发病机制的第一步。
J Pathol. 2004 Jun;203(2):631-7. doi: 10.1002/path.1570.
Zotero 插件